ANDA 89109, held by Teva. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 89109 (Promethazine Hydrochloride), held by Teva, was first approved by FDA on Sep 10, 1985, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 10, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride25MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
| Aug 30, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Feb 18, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Sep 10, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters